172 related articles for article (PubMed ID: 1122669)
1. Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.
Vesell ES; Shapiro JR; Passananti T; Jorgensen H; Shively CA
Clin Pharmacol Ther; 1975 Jan; 17(1):48-56. PubMed ID: 1122669
[TBL] [Abstract][Full Text] [Related]
2. Drug metabolism in thyroid disease.
Eichelbaum M
Clin Pharmacokinet; 1976; 1(5):339-50. PubMed ID: 797503
[TBL] [Abstract][Full Text] [Related]
3. Changes in drug metabolism in children with thyroid disorders.
Saenger P; Rifkind AB; New MI
J Clin Endocrinol Metab; 1976 Jan; 42(1):155-9. PubMed ID: 1249184
[TBL] [Abstract][Full Text] [Related]
4. Influence of thyroid status on plasma half-life of antipyrine in man.
Eichelbaum M; Bodem G; Gugler R; Schneider-Deters D; Dengler HJ
N Engl J Med; 1974 May; 290(19):1040-2. PubMed ID: 4821905
[No Abstract] [Full Text] [Related]
5. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
6. Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction.
Hepner GW; Vesell ES
Am J Dig Dis; 1975 Jan; 20(1):9-12. PubMed ID: 1115054
[TBL] [Abstract][Full Text] [Related]
7. Proceedings: Changes in drug metabolizing ability in thyroid disease.
Crooks J; Hedley AJ; Macnee C; Stevenson IH
Br J Pharmacol; 1973 Sep; 49(1):156P-157P. PubMed ID: 4787533
[No Abstract] [Full Text] [Related]
8. Unaltered metabolism of phenytoin in thyroid disorders.
Mølholm Hansen J; Skovsted L; Kampmann JP; Lumholtz BI; Siersbaek-Nielsen K
Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):343-6. PubMed ID: 581029
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties and bioavailability of methimazole.
Jansson R; Lindström B; Dahlberg PA
Clin Pharmacokinet; 1985; 10(5):443-50. PubMed ID: 4042519
[TBL] [Abstract][Full Text] [Related]
10. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
Reidenberg MM; Vesell ES
Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
[TBL] [Abstract][Full Text] [Related]
11. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
12. Effects of thyroid dysfunction on propranolol kinetics.
Riddell JG; Neill JD; Kelly JG; McDevitt DG
Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675
[TBL] [Abstract][Full Text] [Related]
13. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance.
Elin RJ; Vesell ES; Wolff SM
Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
Nicoloff JT; Low JC; Dussault JH; Fisher DA
J Clin Invest; 1972 Mar; 51(3):473-83. PubMed ID: 4110897
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic treatment of intact and hypophysectomized rats with thyroid-stimulating hormone on the metabolism of [35S]methimazole and [35S]propylthiouracil.
Lees JF; Alexander WD
Endocrinology; 1978 Oct; 103(4):1394-400. PubMed ID: 744151
[TBL] [Abstract][Full Text] [Related]
16. Toxicities associated with 1-month treatment with propylthiouracil (PTU) and methimazole (MMI) in male rats.
Nambiar PR; Palanisamy GS; Okerberg C; Wolford A; Walters K; Buckbinder L; Reagan WJ
Toxicol Pathol; 2014 Aug; 42(6):970-83. PubMed ID: 24067673
[TBL] [Abstract][Full Text] [Related]
17. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
Kappas A; Anderson KE; Conney AH; Alvares AP
Clin Pharmacol Ther; 1976 Dec; 20(6):643-53. PubMed ID: 991535
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 35S-labelled antithyroid drugs in man.
Alexander WD; Evans V; MacAulay A; Gallagher TF; Londono J
Br Med J; 1969 May; 2(5652):290-1. PubMed ID: 4180995
[TBL] [Abstract][Full Text] [Related]
19. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.
Saberi M; Sterling FH; Utiger RD
J Clin Invest; 1975 Feb; 55(2):218-23. PubMed ID: 1173242
[TBL] [Abstract][Full Text] [Related]
20. Elimination of antipyrine from saliva as a measure of metabolism in man.
Welch RM; DeAngelis RL; Wingfield M; Farmer TW
Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
